On February 2, 2026, Medtronic (MDT) disclosed an insider trading transaction. Executive Blomquist Denise L. sold 148 shares on January 29, 2026.
【Recent Insider Transactions】
Disclosure Date
Position
Name
Transaction Date
Buy/Sell
Quantity
Price per Share/USD
Total Amount/USD
February 2, 2026
Executive
Blomquist Denise L.
January 29, 2026
Sell
148
101.00
$14,900
December 17, 2025
Director
Martha Geoffrey
December 15, 2025
Sell
1564
99.87
$156,200
December 17, 2025
Executive
Marinaro Michael
December 15, 2025
Sell
1371
99.87
$136,900
December 17, 2025
Executive
Wall Brett A.
December 15, 2025
Sell
439
99.87
$4,380
December 9, 2025
Executive
KIIL HARRY SKIP
December 5, 2025
Sell
1702
101.36
$172,500
November 21, 2025
Executive
Smith Gregory L
November 19, 2025
Sell
1942
101.99
$198,100
November 21, 2025
Executive
Smith Gregory L
November 19, 2025
Sell
24,200
101.93
$2,465,300
November 21, 2025
Executive
Smith Gregory L
November 19, 2025
Sell
1995
102.03
$203,500
November 21, 2025
Executive
Smith Gregory L
November 19, 2025
Sell
500
102.08
$5,100
November 21, 2025
Executive
Smith Gregory L
November 19, 2025
Sell
825
102.04
$82,400
【Company Information】
Medtronic Limited was established in 1949 and is the successor registered company of Medtronic, Inc. in Minnesota. Medtronic, Inc. was registered in Ireland as a private limited company on June 12, 2014, and re-registered as a public limited company effective January 26, 2015. The company was established to facilitate the acquisition of Covidien, a public limited company incorporated under Irish law, which was wound up on January 26, 2015 (the acquisition date). Medtronic Limited, headquartered in Dublin, Ireland, is one of the world’s largest medical technology, services, and solutions companies, serving hundreds of millions of people worldwide by alleviating pain, restoring health, and extending life. Today, it provides services to hospitals, physicians, clinicians, and patients in over 150 countries. The company’s main clients include hospitals, clinics, third-party healthcare providers, distributors, and other organizations, including government healthcare programs and group purchasing organizations (GPOs).
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
US Stock Insider Trading | Medtronic Discloses 1 Insider Transaction on February 2
On February 2, 2026, Medtronic (MDT) disclosed an insider trading transaction. Executive Blomquist Denise L. sold 148 shares on January 29, 2026.
【Recent Insider Transactions】
【Company Information】
Medtronic Limited was established in 1949 and is the successor registered company of Medtronic, Inc. in Minnesota. Medtronic, Inc. was registered in Ireland as a private limited company on June 12, 2014, and re-registered as a public limited company effective January 26, 2015. The company was established to facilitate the acquisition of Covidien, a public limited company incorporated under Irish law, which was wound up on January 26, 2015 (the acquisition date). Medtronic Limited, headquartered in Dublin, Ireland, is one of the world’s largest medical technology, services, and solutions companies, serving hundreds of millions of people worldwide by alleviating pain, restoring health, and extending life. Today, it provides services to hospitals, physicians, clinicians, and patients in over 150 countries. The company’s main clients include hospitals, clinics, third-party healthcare providers, distributors, and other organizations, including government healthcare programs and group purchasing organizations (GPOs).